Upside to current share price: 78% Hamburg, 7 October 2024 – The NAGA Group AG ( XETRA: N4G, ISIN: DE000A161NR7) maintains a ...

As an active trader in the financial markets, you probably know better than anyone that any edge, trading skill, or unique ...

Last fall, Enbridge (NYSE: ENB) made a bold strike. The Canadian pipeline and utility giant agreed to buy three natural gas utilities from in a $14 billion deal. The transaction would create the ...

In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, Dalata Hotel Group plc announces that: The above figure may be used by shareholders as a denominator for ...

Super Micro Computer (NASDAQ: SMCI) stock is still up more than 1,000% over the last three years, thanks to rising demand for its high-performance rack servers tied to artificial intelligence (AI).

Heavy losses for Cairn Homes plc today as the stock fell by -€0.100 (-5.000%). EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor ...

How much will Social Security benefits rise in the new year? That's a big question on a lot of people's minds as we get closed to nailing down an official 2025 cost-of-living adjustment (COLA). The ...

EQS-News: Vonovia SE / Key word (s): Disposal Three Transactions for Combined Liquidity Generation of € 1.8 billion ...

Investors love to get inspiration from Warren Buffett. He has shepherded his holding company, Berkshire Hathaway, to incredible, market-beating returns over time, providing sage advice for followers ...

With a sales presence in more than 200 countries and territories across the globe, as well as top beverage options like its namesake soft drink, Dasani water, and Powerade sports drink, among many ...

Dividend investing can create substantial passive income over time. A conservative example illustrates this potential: Investing $10,000 annually for 40 years in a stock yielding 3.1% with 2.5% annual ...

Wave Life Sciences (NASDAQ: WVE) and Sarepta Therapeutics (NASDAQ: SRPT) are both riskier than the typical biotech, even when considering their stage of maturity. But with more uncertainty often comes ...